Literature DB >> 9089043

Role of symptom scoring and uroflowmetry in patients with diabetic cystopathy.

M Ishigooka1, Y Suzuki, S Hayami, O Ichiyanagi, T Hashimoto, T Nakada.   

Abstract

Forty-two patients with diabetes mellitus were evaluated by uroflowmetry and the AUA Symptom Index. After urodynamic and physiological investigations 12 patients were diagnosed as having diabetic cystopathy, while 22 patients as being urodynamically normal. In patients with diabetic cystopathy, most of the parameters in uroflowmetry were significantly different from those of normal subjects. Subjective symptom assessment revealed increased total obstructive scoring (p < 0.05). However, irritative symptom indexes in patients with diabetic cystopathy were not different from those of the normal subjects. Although uroflowmetry and the AUA Symptom Index are not specific to identify detrusor impairment, these methods appeared to be useful to decide upon further urodynamic investigations.

Entities:  

Mesh:

Year:  1996        PMID: 9089043     DOI: 10.1007/bf02550724

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  Abnormalities of bladder innervation in diabetes mellitus.

Authors:  J T Andersen; W E Bradley
Journal:  Urology       Date:  1976-04       Impact factor: 2.649

3.  A new method for quantitative evaluation of bladder sensibility.

Authors:  C Frimodt-Moller
Journal:  Scand J Urol Nephrol       Date:  1972

4.  Neuropathology of diabetic neurogenic bladder.

Authors:  A R Mastri
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

5.  Treatment of diabetic cystopathy.

Authors:  C Frimodt-Møller; S Mortensen
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

6.  Diabetic cystopathy: epidemiology and related disorders.

Authors:  C Frimodt-Møller
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

7.  Development of urinary bladder dysfunction in diabetes mellitus.

Authors:  M Ellenberg
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

8.  Urodynamic findings in patients with diabetic cystopathy.

Authors:  S A Kaplan; A E Te; J G Blaivas
Journal:  J Urol       Date:  1995-02       Impact factor: 7.450

Review 9.  Diabetic cystopathy.

Authors:  S A Kaplan; J G Blaivas
Journal:  J Diabet Complications       Date:  1988 Jul-Sep

10.  Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.

Authors:  M B Chancellor; D A Rivas; F X Keeley; M A Lotfi; L G Gomella
Journal:  Br J Urol       Date:  1994-08
  10 in total
  3 in total

1.  Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study.

Authors:  Aruna V Sarma; Alka Kanaya; Leroy M Nyberg; John W Kusek; Eric Vittinghoff; Brandy Rutledge; Patricia A Cleary; Patricia Gatcomb; Jeanette S Brown
Journal:  Urology       Date:  2009-04-10       Impact factor: 2.649

2.  Ultra-structural morphological abnormalities of the urinary bladder in streptozotocin-induced diabetic female rats.

Authors:  Diaa E E Rizk; Rengasamy K Padmanabhan; Saeed Tariq; Mohamed Shafiullah; Ijaz Ahmed
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-14

3.  Urinary incontinence among women with type 1 diabetes--how common is it?

Authors:  Aruna V Sarma; Alka M Kanaya; Leroy M Nyberg; John W Kusek; Eric Vittinghoff; Brandy Rutledge; Patricia A Cleary; Patricia Gatcomb; Jeanette S Brown
Journal:  J Urol       Date:  2009-01-18       Impact factor: 7.450

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.